Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
IBRX - REVENUE
Revenue IBRX - ImmunityBio, Inc.
622 K
LAST VALUE
-18.39%
2 YEAR CAGR
67.62%
5 YEAR CAGR
0.36%
10 YEAR CAGR